1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global ACL Reconstruction Procedures Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global ACL Reconstruction Procedures Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
5.2. Technological Advancements
5.3. Key Industry Events
5.4. Regulatory Scenario
5.5. Overview of ACL Reconstruction Surgeries
5.6. Overview of Orthopedic Injuries and Disease prevalence across globe
6. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
6.3.1. Extra-articular
6.3.2. Intra-articular
6.3.2.1. Patellar Tendon Autograft
6.3.2.2. Hamstring Tendon Autograft
6.3.2.3. Quadriceps Tendon Autograft
6.3.2.4. Others
6.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Type
7. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Fixation Type, 2017-2031
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
7.3.1. Femoral
7.3.2. Tibial
7.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Fixation Type
8. Global ACL Reconstruction Procedures Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Orthopedic Centers
8.3.3. Others
8.4. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by End-user
9. Global ACL Reconstruction Procedures Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global ACL Reconstruction Procedures Market Attractiveness Analysis, by Region
10. North America ACL Reconstruction Procedures Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
10.2.1. Extra-articular
10.2.2. Intra-articular
10.2.2.1. Patellar Tendon Autograft
10.2.2.2. Hamstring Tendon Autograft
10.2.2.3. Quadriceps Tendon Autograft
10.2.2.4. Others
10.3. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
10.3.1. Femoral
10.3.2. Tibial
10.4. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Orthopedic Centers
10.4.3. Others
10.5. North America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. North America ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
11. Europe ACL Reconstruction Procedures Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
11.2.1. Extra-articular
11.2.2. Intra-articular
11.2.2.1. Patellar Tendon Autograft
11.2.2.2. Hamstring Tendon Autograft
11.2.2.3. Quadriceps Tendon Autograft
11.2.2.4. Others
11.3. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
11.3.1. Femoral
11.3.2. Tibial
11.4. Europe ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Orthopedic Centers
11.4.3. Others
11.5. Europe ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
12. Asia Pacific ACL Reconstruction Procedures Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
12.2.1. Extra-articular
12.2.2. Intra-articular
12.2.2.1. Patellar Tendon Autograft
12.2.2.2. Hamstring Tendon Autograft
12.2.2.3. Quadriceps Tendon Autograft
12.2.2.4. Others
12.3. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
12.3.1. Femoral
12.3.2. Tibial
12.4. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Orthopedic Centers
12.4.3. Others
12.5. Asia Pacific ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
13. Latin America ACL Reconstruction Procedures Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
13.2.1. Extra-articular
13.2.2. Intra-articular
13.2.2.1. Patellar Tendon Autograft
13.2.2.2. Hamstring Tendon Autograft
13.2.2.3. Quadriceps Tendon Autograft
13.2.2.4. Others
13.3. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
13.3.1. Femoral
13.3.2. Tibial
13.4. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Orthopedic Centers
13.4.3. Others
13.5. Latin America ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
14. Middle East & Africa ACL Reconstruction Procedures Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Type, 2017–2031
14.2.1. Extra-articular
14.2.2. Intra-articular
14.2.2.1. Patellar Tendon Autograft
14.2.2.2. Hamstring Tendon Autograft
14.2.2.3. Quadriceps Tendon Autograft
14.2.2.4. Others
14.3. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Fixation Type, 2017–2031
14.3.1. Femoral
14.3.2. Tibial
14.4. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Orthopedic Centers
14.4.3. Others
14.5. Middle East & Africa ACL Reconstruction Procedures Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa ACL Reconstruction Procedures Market Attractiveness Analysis, 2017–2031
15. Competitive Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Arthrex, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Strategic Overview
15.3.1.4. SWOT Analysis
15.3.2. CITIEFFE S.R.L.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Strategic Overview
15.3.2.4. SWOT Analysis
15.3.3. CONMED Corporation
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. Strategic Overview
15.3.3.5. SWOT Analysis
15.3.4. DJO Global, Inc.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Strategic Overview
15.3.4.4. SWOT Analysis
15.3.5. Johnson & Johnson Services, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. Strategic Overview
15.3.5.5. SWOT Analysis
15.3.6. Medtronic
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. Strategic Overview
15.3.6.5. SWOT Analysis
15.3.7. Miach Orthopaedics
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Strategic Overview
15.3.7.4. SWOT Analysis
15.3.8. Meira Corporation
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Strategic Overview
15.3.8.4. SWOT Analysis
15.3.9. RTI Surgical
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Strategic Overview
15.3.9.4. SWOT Analysis
15.3.10. Smith+Nephew
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. Strategic Overview
15.3.10.5. SWOT Analysis
15.3.11. Stryker Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. Strategic Overview
15.3.11.5. SWOT Analysis
15.3.12. Tissue Regenix Group
15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.12.2. Product Portfolio
15.3.12.3. Strategic Overview
15.3.12.4. SWOT Analysis
15.3.13. Zimmer Biomet Holdings, Inc.
15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.13.2. Product Portfolio
15.3.13.3. Financial Overview
15.3.13.4. Strategic Overview
15.3.13.5. SWOT Analysis